The effect of azithromycin on sputum inflammatory markers in bronchiectasis von Terpstra, L C, Altenburg, J, Doodeman, H J, Piñeros, Y S Sabogal, Lutter, R, Heijerman, H G M, Boersma, W G

Volltext

Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype von Aalbers, B.L., Brunsveld, J.E., van der Ent, C.K., van den Eijnden, J.C., Beekman, J.M., Heijerman, H.G.M.

Volltext

Sinonasal manifestations of cystic fibrosis: A correlation between genotype and phenotype? von Berkhout, M.C, van Rooden, C.J, Rijntjes, E, Fokkens, W.J, el Bouazzaoui, L.H, Heijerman, H.G.M

Volltext

Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma von de Nijs, S.B., Krop, E.J.M., Portengen, L., Rijssenbeek-Nouwens, L.H., de Vries, D., Weersink, E.J.M., Heijerman, H.G.M., Heederik, D.J.J., Lammers, J.W.J.

Volltext

Non-fasting bioelectrical impedance analysis in cystic fibrosis: Implications for clinical practice and research von Hollander-Kraaijeveld, F.M., Lindeman, Y., de Roos, N.M., Burghard, M., van de Graaf, E.A., Heijerman, H.G.M.

Volltext

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus von Doring, G, Conway, SP, Heijerman, HG, Hodson, ME, Hoiby, N, Smyth, A, Touw, DJ

Volltext

Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement von Hollander-Kraaijeveld, F.M., van Lanen, A.S., de Roos, N.M., van de Graaf, E.A., Heijerman, H.G.M.

Volltext

Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline von Aalbers, B.L., de Winter-de Groot, K.M., Arets, H.G.M., Hofland, R.W., de Kiviet, A.C., van Oirschot-van de Ven, M.M.M., Kruijswijk, M.A., Schotman, S., Michel, S., van der Ent, C.K., Heijerman, H.G.M.

Volltext

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a... von Terpstra, L.C., Altenburg, J., Bronsveld, I., Doodeman, H.J., Rozemeijer, W., Heijerman, H.G.M., Boersma, W.G.

Volltext

CT-abnormalities, bacteriology and symptoms of sinonasal disease in children with Cystic Fibrosis von Berkhout, M.C, Klerx-Melis, F, Fokkens, W.J, Nuijsink, M, van Aalderen, W.M.C, Heijerman, H.G.M

Volltext

Importance of bacteriology in upper airways of patients with Cystic Fibrosis von Berkhout, M.C, Rijntjes, E, el Bouazzaoui, L.H, Fokkens, W.J, Brimicombe, R.W, Heijerman, H.G.M

Volltext

Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males von Aalbers, B.L., Hofland, R.W., Bronsveld, I., de Winter-de Groot, K.M., Arets, H.G.M., de Kiviet, A.C., van Oirschot-van de Ven, M.M.M., Kruijswijk, M.A., Schotman, S., Michel, S., van der Ent, C.K., Heijerman, H.G.M.

Volltext

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N von Vreede, C.L, Berkhout, M.C, Sprij, A.J, Fokkens, W.J, Heijerman, H.G.M

Volltext

Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation von Burghard, M (Marcella), Berkers, G (Gitte), Ghijsen, S (Sophie), Hollander‐Kraaijeveld, FM (Francis), Winter‐de Groot, KM (Karin), Ent, CK (Kors), Heijerman, HGM (Harry), Takken, T (Tim), Hulzebos, HJ (Erik)

Volltext

Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization von van Velzen, A J, Bos, A C, Touw, D J, Tiddens, H A W M, Heijerman, H G M, Janssens, H M

Volltext

Systemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis von Berkhout, M C, van Velzen, A J, Touw, D J, de Kok, B M, Fokkens, W J, Heijerman, H G M

Volltext

The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis von van Velzen, A.J, Uges, J.W.F, Le Brun, P.P.H, Shahbabai, P, Touw, D.J, Heijerman, H.G.M

Volltext

Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study von Westerman, E.M, De Boer, A.H, Le Brun, P.P.H, Touw, D.J, Roldaan, A.C, Frijlink, H.W, Heijerman, H.G.M

Volltext

Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study von Westerman, E.M., de Boer, A.H., Le Brun, P.P.H., Touw, D.J., Frijlink, H.W., Heijerman, H.G.M.

Volltext

Authors’ response: Letter to the Editor ‘Anaemia and iron deficiency in relation to fatigue in cystic fibrosis von Nap-van der Vlist, M.M., Burghard, M., Hulzebos, H.J., Doeleman, W.R., Heijerman, H.G.M., van der Ent, C.K., Nijhof, S.L.

Volltext